S

Schuster Medical Research Institute | Sherman Oaks, CA

Research site

(Unclaimed)

Location

5000 Van Nuys Boulevard, Suite 216, Sherman Oaks, California, United States of America

Site insights

Top conditions

Top treatments

SEP-363856

KarXT

Cariprazine

Bapineuzumab

Atogepant

MK-8189

Lasmiditan

BMS-820836

Oral

Leuco-methylthioninium Bis(Hydromethanesulfonate)

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

2 of 38 total trials

A Study to Assess Adverse Events and Change in Disease Activity of Oral Icalcaprant in Adult Participants With Bipolar I or II Disorder

Bipolar disorder is a severe chronic mood disorder that affects up to 4% of the adult population and 1.8% of the pediatric population in the United S...

Enrolling

Bipolar II Disorder

Bipolar I Disorder

Drug: Icalcaprant

Drug: Placebo for Icalcaprant

A Trial of the Efficacy and Safety of SEP-363856 in Acutely Psychotic Participants With Schizophrenia

Evaluate the efficacy and safety of Ulotaront (SEP-363856) in acutely psychotic subjects with schizophrenia

Enrolling

Schizophrenia

Drug: SEP-363856

Other: Placebo

Trial sponsors

T

Clinical trials

Find clinical trials Trials by location

Research sites

Find research sites Learn about CTV for professionals

Resources

Contact CTV support

Legal

Privacy Notice Terms